Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteers

Am J Trop Med Hyg. 1989 Feb;40(2):128-30. doi: 10.4269/ajtmh.1989.40.128.

Abstract

Plasmodium falciparum infected Anopheles stephensi, taken from a group of mosquitoes which had been used to challenge recipients of (NANP)3-TT vaccine, were tested for P. falciparum sporozoite content by an immunoradiometric assay. Seventy-six percent were infected with mean and median sporozoite equivalents per mosquito of 220,994 and 217,398, respectively (SD = 54,911). This sporozoite density is greater than that usually found in the field. These data suggest that this challenge for evaluating P. falciparum sporozoite vaccines is a demanding test of immunity.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anopheles / parasitology*
  • Antigens, Protozoan / analysis
  • Clinical Trials as Topic / methods
  • Humans
  • Malaria / prevention & control
  • Plasmodium falciparum / immunology*
  • Plasmodium falciparum / isolation & purification
  • Vaccines / immunology

Substances

  • Antigens, Protozoan
  • Vaccines